A citation-based method for searching scientific literature

Seung Tae Kim, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Whan Park, Neunggyu Park, Hukeun Lee, Sung Hee Hong, Song-Jae Lee, Seong-Won Song, Kyung Kim, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Do-Hyun Nam, Jeong-Won Lee, Keunchil Park, Kyoung-Mee Kim, Jeeyun Lee. Ther Adv Med Oncol 2020
Times Cited: 6







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting MET in cancer: rationale and progress.
Ermanno Gherardi, Walter Birchmeier, Carmen Birchmeier, George Vande Woude. Nat Rev Cancer 2012
50

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Daniel V T Catenacci, Niall C Tebbutt, Irina Davidenko, André M Murad, Salah-Eddin Al-Batran, David H Ilson, Sergei Tjulandin, Evengy Gotovkin, Boguslawa Karaszewska, Igor Bondarenko,[...]. Lancet Oncol 2017
183
50

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
Ermanno Gherardi, Sara Sandin, Maxim V Petoukhov, John Finch, Mark E Youles, Lars-Göran Ofverstedt, Ricardo N Miguel, Tom L Blundell, George F Vande Woude, Ulf Skoglund,[...]. Proc Natl Acad Sci U S A 2006
156
33

c-Met is essential for wound healing in the skin.
Jolanta Chmielowiec, Malgorzata Borowiak, Markus Morkel, Theresia Stradal, Barbara Munz, Sabine Werner, Jürgen Wehland, Carmen Birchmeier, Walter Birchmeier. J Cell Biol 2007
231
33



Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors.
Michael S Gordon, Christopher S Sweeney, David S Mendelson, S Gail Eckhardt, Abraham Anderson, Darrin M Beaupre, Daniel Branstetter, Teresa L Burgess, Angela Coxon, Hongjie Deng,[...]. Clin Cancer Res 2010
137
33

Met, metastasis, motility and more.
Carmen Birchmeier, Walter Birchmeier, Ermanno Gherardi, George F Vande Woude. Nat Rev Mol Cell Biol 2003
33

Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer.
Srinivasa P Pothula, Zhihong Xu, David Goldstein, Neil Merrett, Romano C Pirola, Jeremy S Wilson, Minoti V Apte. Oncotarget 2017
38
33

c-Met is a marker of pancreatic cancer stem cells and therapeutic target.
Chenwei Li, Jing-Jiang Wu, Mark Hynes, Joseph Dosch, Bedabrata Sarkar, Theodore H Welling, Marina Pasca di Magliano, Diane M Simeone. Gastroenterology 2011
262
33

Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression.
Hyun Jung Kim, Sukmook Lee, Yong-Seok Oh, Ha Kyun Chang, Young Sang Kim, Sung Hee Hong, Jung Yong Kim, Young-Whan Park, Song-Jae Lee, Seong-Won Song,[...]. Front Oncol 2019
6
33

Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas.
Cem Baykal, Ayşe Ayhan, Atakan Al, Kunter Yüce, Ali Ayhan. Gynecol Oncol 2003
65
33

Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.
Tomoyuki Nagai, Tokuzo Arao, Kazuyuki Furuta, Kazuko Sakai, Kanae Kudo, Hiroyasu Kaneda, Daisuke Tamura, Keiichi Aomatsu, Hideharu Kimura, Yoshihiko Fujita,[...]. Mol Cancer Ther 2011
93
16

Quantifying Drug Combination Synergy along Potency and Efficacy Axes.
Christian T Meyer, David J Wooten, B Bishal Paudel, Joshua Bauer, Keisha N Hardeman, David Westover, Christine M Lovly, Leonard A Harris, Darren R Tyson, Vito Quaranta. Cell Syst 2019
64
16

Cell-type-resolved quantitative proteomics of murine liver.
S Babak Azimifar, Nagarjuna Nagaraj, Juergen Cox, Matthias Mann. Cell Metab 2014
105
16

Network modeling of TGFβ signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation.
Steven Nathaniel Steinway, Jorge G T Zañudo, Wei Ding, Carl Bart Rountree, David J Feith, Thomas P Loughran, Reka Albert. Cancer Res 2014
146
16

Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma.
Mustafa A Barbhuiya, Adam C Mirando, Brian W Simons, Ghali Lemtiri-Chlieh, Jordan J Green, Aleksander S Popel, Niranjan B Pandey, Phuoc T Tran. Oncotarget 2017
6
16

Heterogeneous kinetics of AKT signaling in individual cells are accounted for by variable protein concentration.
René Meyer, Lorenza A D'Alessandro, Sandip Kar, Bernhard Kramer, Bin She, Daniel Kaschek, Bettina Hahn, David Wrangborg, Johan Karlsson, Mats Kvarnström,[...]. Front Physiol 2012
28
16

Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.
S Rong, S Segal, M Anver, J H Resau, G F Vande Woude. Proc Natl Acad Sci U S A 1994
341
16

A Comparison of Proteins Expressed between Human and Mouse Adipose-Derived Mesenchymal Stem Cells by a Proteome Analysis through Liquid Chromatography with Tandem Mass Spectrometry.
Saifun Nahar, Yoshiki Nakashima, Chika Miyagi-Shiohira, Takao Kinjo, Naoya Kobayashi, Issei Saitoh, Masami Watanabe, Hirofumi Noguchi, Jiro Fujita. Int J Mol Sci 2018
7
16


A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.
Adam C Mirando, Jikui Shen, Raquel Lima E Silva, Zenny Chu, Nicholas C Sass, Valeria E Lorenc, Jordan J Green, Peter A Campochiaro, Aleksander S Popel, Niranjan B Pandey. JCI Insight 2019
23
16

AKT/PKB Signaling: Navigating the Network.
Brendan D Manning, Alex Toker. Cell 2017
16

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.
Susumu Kobayashi, Titus J Boggon, Tajhal Dayaram, Pasi A Jänne, Olivier Kocher, Matthew Meyerson, Bruce E Johnson, Michael J Eck, Daniel G Tenen, Balázs Halmos. N Engl J Med 2005
16



Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes.
Rachel Barrow-McGee, Naoki Kishi, Carine Joffre, Ludovic Ménard, Alexia Hervieu, Bakhouche A Bakhouche, Alejandro J Noval, Anja Mai, Camilo Guzmán, Luisa Robbez-Masson,[...]. Nat Commun 2016
61
16

Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment.
Kerri-Ann Norton, Chang Gong, Samira Jamalian, Aleksander S Popel. Processes (Basel) 2019
57
16



Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
Arman Jahangiri, Alan Nguyen, Ankush Chandra, Maxim K Sidorov, Garima Yagnik, Jonathan Rick, Sung Won Han, William Chen, Patrick M Flanigan, Dina Schneidman-Duhovny,[...]. Proc Natl Acad Sci U S A 2017
41
16

Liver regeneration.
G K Michalopoulos, M C DeFrances. Science 1997
16

Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice.
Roman L Bogorad, Hao Yin, Anja Zeigerer, Hidenori Nonaka, Vera M Ruda, Marino Zerial, Daniel G Anderson, Victor Koteliansky. Nat Commun 2014
60
16

Corrigendum: Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes.
Rachel Barrow-McGee, Naoki Kishi, Carine Joffre, Ludovic Ménard, Alexia Hervieu, Bakhouche A Bakhouche, Alejandro J Noval, Anja Mai, Camilo Guzmán, Luisa Robbez-Masson,[...]. Nat Commun 2016
11
16

Predicting ligand-dependent tumors from multi-dimensional signaling features.
Helge Hass, Kristina Masson, Sibylle Wohlgemuth, Violette Paragas, John E Allen, Mark Sevecka, Emily Pace, Jens Timmer, Joerg Stelling, Gavin MacBeath,[...]. NPJ Syst Biol Appl 2017
22
16



Comparison of approaches for parameter identifiability analysis of biological systems.
Andreas Raue, Johan Karlsson, Maria Pia Saccomani, Mats Jirstrand, Jens Timmer. Bioinformatics 2014
64
16

Disentangling the Complexity of HGF Signaling by Combining Qualitative and Quantitative Modeling.
Lorenza A D'Alessandro, Regina Samaga, Tim Maiwald, Seong-Hwan Rho, Sandra Bonefas, Andreas Raue, Nao Iwamoto, Alexandra Kienast, Katharina Waldow, Rene Meyer,[...]. PLoS Comput Biol 2015
9
16

Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling.
Tobias Speicher, Beat Siegenthaler, Roman L Bogorad, Raphael Ruppert, Tobias Petzold, Susagna Padrissa-Altes, Marc Bachofner, Daniel G Anderson, Victor Koteliansky, Reinhard Fässler,[...]. Nat Commun 2014
52
16


MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM.
Jessica B Casaletto, Melissa L Geddie, Adnan O Abu-Yousif, Kristina Masson, Aaron Fulgham, Antoine Boudot, Tim Maiwald, Jeffrey D Kearns, Neeraj Kohli, Stephen Su,[...]. Proc Natl Acad Sci U S A 2019
17
16

Analysis of receptor tyrosine kinase internalization using flow cytometry.
Ning Li, Kristen S Hill, Lisa A Elferink. Methods Mol Biol 2008
23
16

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
16


Credibility, Replicability, and Reproducibility in Simulation for Biomedicine and Clinical Applications in Neuroscience.
Lealem Mulugeta, Andrew Drach, Ahmet Erdemir, C A Hunt, Marc Horner, Joy P Ku, Jerry G Myers, Rajanikanth Vadigepalli, William W Lytton. Front Neuroinform 2018
15
16


Protein abundance of AKT and ERK pathway components governs cell type-specific regulation of proliferation.
Lorenz Adlung, Sandip Kar, Marie-Christine Wagner, Bin She, Sajib Chakraborty, Jie Bao, Susen Lattermann, Melanie Boerries, Hauke Busch, Patrick Wuchter,[...]. Mol Syst Biol 2017
42
16


Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.